USD0.000æéå€ååŒÂ  (ET)
1.03BæäŸ¡ç·é¡
25.13çŽè¿12ã¶æPER
TradingKey æ ªåŒã¹ã³ã¢
å¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
äºæž¬å€
ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ããã®è©äŸ¡
ãªã¹ã¯
ç«¶åä»ç€Ÿ
TradingKey æ ªåŒã¹ã³ã¢
å¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
äºæž¬å€
ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ããã®è©äŸ¡
ãªã¹ã¯
ç«¶åä»ç€Ÿ
TradingKeyã®MiMedx Group Incã®æ ªåŒã¹ã³ã¢
é貚: USD æŽæ°æå»: 2025-12-05 äž»èŠã€ã³ãµã€ã
å瀟ã®è²¡åç¶æ³ã¯æ¯èŒçéåžžã«å¥å
šã§ããåç€Ÿã®æ ªäŸ¡ã¯é©æ£äŸ¡æ Œãšè©äŸ¡ãããŠããŸãããŸããæ©é¢æè³å®¶ã«ããèªç¥åºŠã¯éåžžã«é«ãã§ããéå»30æ¥éã§ãè€æ°ã®ã¢ããªã¹ããå瀟ãè²·ããšè©äŸ¡ããŸãããæ ªäŸ¡ã®ããã©ãŒãã³ã¹ã¯äœèª¿ã§ããããã¡ã³ãã¡ã³ã¿ã«ãºãšãã¯ãã«ã«ã¯å
調ã§ããæ ªäŸ¡ã¯æ¯æç·ã𿵿ç·ã®éã§æšªã°ãæšç§»ããŠãããã¬ã³ãžçžå Žã§ã®ã¹ã€ã³ã°ãã¬ãŒãã«é©ããŠããŸãã
MiMedx Group Incã®ã¹ã³ã¢î°î°
å
責äºé
ïŒã¢ããªã¹ãã®ã¬ãŒãã£ã³ã°ããã³ç®æšæ ªäŸ¡ã¯ãæ
å ±æäŸã®ã¿ãç®çãšããŠLSEG Data & AnalyticsãæäŸãããã®ã§ãããæè³å©èšãæ§æãããã®ã§ã¯ãããŸããã
MiMedx Group Incã®æ³šç®ãã€ã³ã
匷ã¿ãªã¹ã¯
å¥å
šæ§
é貚: USD æŽæ°æå»: 2025-12-05å瀟ã®çŸåšã®è²¡åã¹ã³ã¢ã¯9.38ã§ããã€ãªãã¯ãããžãŒ & å»çç ç©¶æ¥çã®å¹³å6.92ãããé«ãæ°Žæºã§ãã 財åç¶æ³ã¯å
調ã§ã ãŸããäºæ¥å¹çã¯é«ãã§ãã ææ°ååæã®åçã¯113.72Mã§ãåå¹Žåææ¯35.30%ã®å¢å ã§ãããäžæ¹ãçŽå©çã¯åå¹Žåææ¯106.89%ã®å¢å ã§ããã
é¢é£èšäº
çŸéããã³çŸéåçç©
ç·è³ç£
è² åµåèš
ããªãŒãã£ãã·ã¥ãããŒ

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
é¢é£èšäº
ç·å£²äžé«
å¶æ¥å©ç
ç·è³ç£
販売費 & äžè¬ç®¡çè²»

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
é¢é£èšäº
å¶æ¥æŽ»åã«ãããã£ãã·ã¥ãããŒ
çšåŒåŸå©ç

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
é¢é£èšäº
å¶æ¥æŽ»åã«ãããã£ãã·ã¥ãããŒ
ç·å£²äžé«

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
é¢é£èšäº
ããªãŒãã£ãã·ã¥ãããŒ

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
MiMedx Group Incã®äŒæ¥äŸ¡å€è©äŸ¡
é貚: USD æŽæ°æå»: 2025-12-05å瀟ã®çŸåšã®ããªã¥ãšãŒã·ã§ã³ã¹ã³ã¢ã¯5.77ã§ããã€ãªãã¯ãããžãŒ & å»çç ç©¶æ¥çã®å¹³å7.05ãããäœãæ°Žæºã§ãã çŸåšã®PERïŒæ ªäŸ¡åççïŒã¯25.04ã§ãçŽè¿é«å€33.45ã33.57%äžåããçŽè¿å®å€-420.62ã1779.55%äžåã£ãŠããŸãã
ããªã¥ãšãŒã·ã§ã³
PER
PBRïŒæ ªäŸ¡çŽè³ç£åçïŒ
PSR
PCFR
æ¥çå
é äœ 42/403

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
äºæž¬å€
é貚: USD æŽæ°æå»: 2025-12-05å瀟ã®çŸåšã®åçäºæž¬ã¹ã³ã¢ã¯8.00ã§ããã€ãªãã¯ãããžãŒ & å»çç ç©¶æ¥çã®å¹³å8.02ãããäœãæ°Žæºã§ãã MiMedx Group Incã®å¹³åç®æšæ ªäŸ¡ã¯12.00ã§ãæé«ã¯13.00ãæäœã¯12.00ã§ãã
ç®æšæ ªäŸ¡

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
CRISPR Therapeutics AG
CRSP
30
Intellia Therapeutics Inc
NTLA
25
Ionis Pharmaceuticals Inc
IONS
24
財åäºæž¬

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
å
責äºé
ïŒã¢ããªã¹ãã®ã¬ãŒãã£ã³ã°ããã³ç®æšæ ªäŸ¡ã¯ãæ
å ±æäŸã®ã¿ãç®çãšããŠLSEG Data & AnalyticsãæäŸãããã®ã§ãããæè³å©èšãæ§æãããã®ã§ã¯ãããŸããã
ã¢ã¡ã³ã¿ã
é貚: USD æŽæ°æå»: 2025-12-05å瀟ã®çŸåšã®äŸ¡æ Œã¢ã¡ã³ã¿ã ã¹ã³ã¢ã¯7.36ã§ããã€ãªãã¯ãããžãŒ & å»çç ç©¶æ¥çã®å¹³å7.13ãããé«ãæ°Žæºã§ãã æšªã°ã: çŸåšãæ ªäŸ¡ã¯æµæç·7.69ãšæ¯æç·6.25ã®éã§æšç§»ããŠãããã¬ã³ãžçžå Žã§ã®ã¹ã€ã³ã°ãã¬ãŒãã«é©ããŠããŸãã
æ¯æç·ã𿵿ç·

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
ææš
î°
î°
æ¬ææšæ©èœã¯ãåçš®ãã¯ãã«ã«ææšãçšããŠéèååã®æ°å€åæãšæ¹åæ§è©äŸ¡ãæäŸããæè¡çãªèŠçŽã衚瀺ããŸãã
æ¬æ©èœã§ã¯MACDã»RSIã»KDJã»StochRSIã»ATRã»CCIã»WRã»TRIXã»MAã®9çš®é¡ã®äž»èŠãã¯ãã«ã«ææšãç¶²çŸ
ããŠããŸããæé軞ã¯ãèªèº«ã®ããŒãºã«åãããŠèª¿æŽå¯èœã§ãã
ãã¯ãã«ã«åæã¯æè³å€æã®äžèŠçŽ ã«éãããæ°å€ã«ããæ¹åæ§è©äŸ¡ã«çµ¶å¯Ÿçãªåºæºã¯ãããŸãããè¡šç€ºçµæã¯ãããŸã§åèæ
å ±ã§ãããææšèšç®ã»èŠçŽã®æ£ç¢ºæ§ã«ã€ããŠåœæ¹ã¯è²¬ä»»ãè² ããããŸãã
ææš
売ã(2)
äžç«(4)
è²·ã(0)
ç§»åå¹³å
売ã(4)
äžç«(0)
è²·ã(2)
æ©é¢æè³å®¶ããã®è©äŸ¡
é貚: USD æŽæ°æå»: 2025-12-05å瀟ã®çŸåšã®æ©é¢æè³å®¶èªç¥åºŠã¹ã³ã¢ã¯7.00ã§ããã€ãªãã¯ãããžãŒ & å»çç ç©¶æ¥çã®å¹³å5.15ãããé«ãæ°Žæºã§ãã ææ°ã®æ©é¢æè³å®¶ä¿ææ¯çã¯70.83%ã§ãåååææ¯1.56%ã®æžå°ãšãªããŸããã æå€§ã®æ©é¢æè³å®¶ã¯ãã³ã¬ãŒãã§ãåèš6.78Mæ ªïŒçºè¡æžæ ªåŒã®4.58%ïŒãä¿æããŠãããä¿ææ ªæ°ã¯1.08%å¢å ããŸããã
æ©é¢æè³å®¶ä¿ææ ª

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
æ ªäž»åå
BlackRock Institutional Trust Company, N.A.
Trigran Investments, Inc.
First Light Asset Management, LLC
State Street Investment Management (US)
Geode Capital Management, L.L.C.
Paradigm Capital Management, Inc.
Dimensional Fund Advisors, L.P.
ãªã¹ã¯î°î°
é貚: USD æŽæ°æå»: 2025-12-05å瀟ã®çŸåšã®ãªã¹ã¯è©äŸ¡ã¹ã³ã¢ã¯6.37ã§ããã€ãªãã¯ãããžãŒ & å»çç ç©¶æ¥çã®å¹³å3.48ãããé«ãæ°Žæºã§ãã å瀟ã®ããŒã¿å€ã¯1.57ã§ãã ããã¯ãäžæçžå Žã§ã¯æ ªäŸ¡ãåžå Žå
šäœïŒææ°ïŒãäžåãåŸåãããäžæ¹ã§ãäžèœçžå Žã§ã¯ãã倧ããªäžèœãçµéšããããšã瀺ããŠããŸãã
S&P 500ææ°ãšã®ããŒã¿å€
1.57
éå»240æ¥éã®æå€§ãããŒããŠã³
+39.60%
éå»240æ¥ã®ãã©ãã£ãªãã£
+47.93%
æ»ã
æ¥æ¬¡ãªã¿ãŒã³ïŒæå€§ïŒ
æ¥æ¬¡ãªã¿ãŒã³ïŒæå°ïŒ
ãªã¹ã¯
ãªã¿ãŒã³/ãããŒããŠã³æ¯ç
ãã©ãã£ãªãã£
å®çŸãã©ãã£ãªãã£
æšæºåãã¥ã«ãŒã¬ã³ãž
ããŠã³ãµã€ããªã¹ã¯èª¿æŽåŸãªã¿ãŒã³
æå€§æ¥æ¬¡äžæãã©ãã£ãªãã£
æå€§æ¥æ¬¡äžèœãã©ãã£ãªãã£
æµåæ§
売買å転çã®å€åå¹
ãã€ãªãã¯ãããžãŒ & å»çç ç©¶
å¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
äºæž¬å€
ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ããã®è©äŸ¡
ãªã¹ã¯
å¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
äºæž¬å€
ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ããã®è©äŸ¡
ãªã¹ã¯
å¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
äºæž¬å€
ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ããã®è©äŸ¡
ãªã¹ã¯
å¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
äºæž¬å€
ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ããã®è©äŸ¡
ãªã¹ã¯

BioCryst Pharmaceuticals Inc
BCRX
å¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
äºæž¬å€
ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ããã®è©äŸ¡
ãªã¹ã¯

Amicus Therapeutics Inc
FOLD
å¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
äºæž¬å€
ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ããã®è©äŸ¡
ãªã¹ã¯
詳现ãèŠã
ãããã質å
TradingKeyã¯ã©ã®ããã«ããŠMiMedx Group Incã®æ ªåŒã¹ã³ã¢ãç®åºãããŸããïŒ
îTradingKeyæ ªåŒã¹ã³ã¢ã¯ã100以äžã®åºç€ããŒã¿ããå°ããã34ã®ææšã«åºã¥ããMiMedx Group Incãå
æ¬çã«è©äŸ¡ããŸãããããã®ææšã¯ã財åå¥å
šæ§ãäŒæ¥ãããã£ãŒã«ãåçäºæž¬ãæ ªäŸ¡ã¢ã¡ã³ã¿ã ãæ©é¢æè³å®¶ã®ä¿¡é ŒåºŠããªã¹ã¯è©äŸ¡ã®6ã€ã®äž»èŠãªãã£ã¡ã³ã·ã§ã³ã«åé¡ãããæè³å®¶ã«MiMedx Group Incã®ããã©ãŒãã³ã¹ãšèŠéããå€è§çã«æç€ºããŸãã
MiMedx Group Incã®è²¡åå¥å
šæ§ã¹ã³ã¢ã¯ã©ã®ããã«ç®åºãããŸããïŒ
îMiMedx Group Incã®è²¡åå¥å
šæ§ã¹ã³ã¢ãçæããã«ãããã財ååºç€ãåçã®è³ªãéå¶å¹çãæé·å¯èœæ§ãæ ªäž»ãžã®ãªã¿ãŒã³ãªã©ãè€æ°ã®äž»èŠãªèгç¹ããåçš®è²¡åææšãåæããŠããŸãããããã®å
æ¬çãªããŒã¿ãçµ±åããããšã§ã財åå¥å
šæ§ã¹ã³ã¢ã¯MiMedx Group Incã®å®å®æ§ãéå¶å¹çãæé·æ§ããã³æ ªäž»ãžã®ãªã¿ãŒã³ãåæ ããæè³å®¶ãå©å®³é¢ä¿è
ã®åççãªæææ±ºå®ããµããŒãããŸããã¹ã³ã¢ãé«ãã»ã©ãMiMedx Group Incã®è²¡åå¥å
šæ§ãè¯å¥œã§ããããšã瀺ããŸãã
MiMedx Group Incã®äŒæ¥äŸ¡å€è©äŸ¡ã¹ã³ã¢ã¯ã©ã®ããã«ç®åºãããŸããïŒ
îMiMedx Group Inc ã®äŒæ¥äŸ¡å€è©äŸ¡ã¹ã³ã¢ãç®åºããããã«ãP/EãP/BãP/Sãããã³ P/CF ãå«ãè€æ°ã®äž»èŠãªè²¡åææšã䜿çšããŸãããããã®ææšã¯ãMiMedx Group Inc ã®åžå ŽäŸ¡å€ãå©çãè³ç£ã売äžããã£ãã·ã¥ãããŒãšæ¯èŒããããšã§ãäŒæ¥äŸ¡å€ãè©äŸ¡ããããã®äž»èŠãªææšãšãªããŸãããããã®ææšãç·åçã«åæããããšã§ãè©äŸ¡ã¹ã³ã¢ã¯åžå ŽãçŸåšã©ã®ããã« MiMedx Group Inc ã®äŸ¡å€ãæããŠãããã ãã§ãªããå°æ¥ã®åçåãæé·å¯èœæ§ãåæ ããããæ
å ±ã«åºã¥ããæè³å€æãæ¯æŽããŸããã¹ã³ã¢ãé«ãã»ã©ãMiMedx Group Inc ã®è©äŸ¡ããã劥åœã§ããããšã瀺ããŸãã
MiMedx Group Incã®åçäºæž¬ã¹ã³ã¢ã¯ã©ã®ããã«ç®åºãããŸããïŒ
îMiMedx Group Incã®åçäºæž¬ã¹ã³ã¢ãç®åºããéã«ã¯ãã¢ããªã¹ãè©äŸ¡ã財åäºæž¬ããµããŒãããã³ã¬ãžã¹ã¿ã³ã¹æ°Žæºã忥ä»ç€Ÿãšã®æ¯èŒãšãã£ãããŸããŸãªäž»èŠææšãèæ
®ããŸããçŸåšã®è©äŸ¡ããã³ç®æšæ ªäŸ¡ã¯ã¢ããªã¹ãã®æåŸ
ãçŽæ¥åæ ããŠãããäžæäœå°ã¯éæã®æé·å¯èœæ§ã«å¯ŸããèŠè§£ã瀺ããŸãã1æ ªåœããå©çïŒEPSïŒã売äžé«ãçŽå©çã婿ãã»çšåŒãåå©çïŒEBITïŒãªã©ã®è²¡åææšã¯ãåçæ§ãè©äŸ¡ããããã®äžå¿çãªåºæºãšãªããŸããç®æšæ ªäŸ¡ã®é«å€ã»äžå€®å€ã»å®å€ã®ã¬ã³ãžãåæããããšã«ãããäŸ¡æ Œãã¬ã³ããææ¡ããäž»èŠãªãµããŒãããã³ã¬ãžã¹ã¿ã³ã¹æ°Žæºãç¹å®ã§ããŸãããããã®ææšã忥ä»ç€Ÿãšæ¯èŒããããšã§ãéæã®ããã©ãŒãã³ã¹ã«æèãäžããããããçŸå®çãªæåŸ
å€ãèšå®ããã®ã«åœ¹ç«ã¡ãŸãããããã®èŠçŽ ãç·åããŠåœ¢æãããåçäºæž¬ã¹ã³ã¢ã¯ãéæã®æåŸ
ããã財åããã©ãŒãã³ã¹ãšæé·å¯èœæ§ãæ£ç¢ºã«åæ ããŸããã¹ã³ã¢ãé«ãã»ã©ãã¢ããªã¹ããMiMedx Group Incã®å°æ¥ã«å¯ŸããŠããæ¥œèгçã§ããããšã瀺ããŸãã
MiMedx Group Incã®æ ªäŸ¡ã¢ã¡ã³ã¿ã ã¹ã³ã¢ã¯ã©ã®ããã«ç®åºãããŸããïŒ
îMiMedx Group Incã®äŸ¡æ Œã¢ã¡ã³ã¿ã ã¹ã³ã¢ãç®åºããéããµããŒãã¬ãã«ãã¬ãžã¹ã¿ã³ã¹ã¬ãã«ãåºæ¥é«ææšãªã©ã®ã¢ã¡ã³ã¿ã ææšãåæããŸãããµããŒãã¬ãã«ã¯ãè²·ãã®é¢å¿ã匷ããããã«äžèœããªãããäŸ¡æ Œãæ¯ããæ°Žæºãæå³ããŸããäžæ¹ãã¬ãžã¹ã¿ã³ã¹ã¬ãã«ã¯ã売ãå§åã«ãã£ãŠäŸ¡æ Œã®äžæãæããããæ°Žæºã瀺ããŸããå
žåçãªäŸ¡æ Œåž¯ã«ãããåºæ¥é«ãšç·åºæ¥é«ã®äž¡æ¹ãåæããããšã§ãåžå Žå
šäœã®æŽ»åç¶æ³ããã³æµåæ§ãè©äŸ¡ããŸãããããã®ææšã掻çšããããšã§ãäŸ¡æ Œãã¬ã³ãããã®å€åã®å¯èœæ§ãææ¡ããå°æ¥ã®åçãããæ£ç¢ºã«äºæž¬ããããšãã§ããŸãããã®å
æ¬çãªææ³ã¯åžå Žã»ã³ãã¡ã³ããåæ ããMiMedx Group Incã®äŸ¡æ Œã«é¢ããåççãªäºæž¬ãå¯èœã«ããŸããã¹ã³ã¢ãé«ãã»ã©ãMiMedx Group Incã®çæçãªäŸ¡æ Œãã¬ã³ããããå®å®ããŠããããšã瀺ããŸãã
MiMedx Group Incã®æ©é¢æè³å®¶ä¿¡é ŒåºŠã¹ã³ã¢ã¯ã©ã®ããã«ç®åºãããŸããïŒ
îMiMedx Group Incã®æ©é¢ä¿¡é ŒåºŠã¹ã³ã¢ãç®åºããããã«ãæ©é¢ã«ããæ ªåŒã®ä¿ææ¯çãšä¿ææ ªæ°ã®äž¡æ¹ãåæããŸããæ©é¢ã®ä¿ææ¯çãé«ãããšã¯ãããæè³å®¶ãMiMedx Group Incã«å¯ŸããŠåŒ·ãä¿¡é Œãæã£ãŠããããšã瀺ããäžè¬çã«ããžãã£ããªã·ã°ãã«ãšãããŠããŸããä¿ææ ªæ°ã確èªããããšã§ãæ©é¢ããã®æ ªåŒãžã©ãã»ã©ã³ãããããŠããããã©ã®ãããªå§¿å¢ããšã£ãŠãããã«ã€ããŠããæ·±ãæŽå¯ãåŸãããŸããæ©é¢æè³å®¶ã¯ãæè³å€æã«å
ç«ã£ãŠç¶¿å¯ãªåæãè¡ãã®ãäžè¬çã§ããããããæ©é¢ä¿¡é ŒåºŠãææ¡ããããšã§ãå©çäºæž¬ãæé©åã§ããäŒæ¥ã®å°æ¥çãªæ¥çžŸãåžå Žã®å®å®æ§ã«é¢ããããä¿¡é Œæ§ã®é«ãèŠç¹ãåŸãããŸããã¹ã³ã¢ãé«ãã»ã©ãMiMedx Group Incã«å¯Ÿããæ©é¢ã®æ¯æã匷ãããšã瀺ããŸãã
ç§ãã¡ã¯ã©ã®ããã«ããŠMiMedx Group Incã®ãªã¹ã¯ç®¡çã¹ã³ã¢ãç®åºããŠããŸããïŒ
îMiMedx Group Incã®ãªã¹ã¯ç®¡çã¹ã³ã¢ãè©äŸ¡ããã«ããããåçããªã¹ã¯ããã©ãã£ãªãã£ãæµåæ§ã«é¢é£ããè€æ°ã®äž»èŠææšãåæããŸãã1æ¥ã®æé«ããã³æäœãªã¿ãŒã³ã¯å©çããã³æå€±ã®æœåšçãªèŠæš¡ã瀺ããã·ã£ãŒãã¬ã·ãªã¯ãªã¹ã¯èª¿æŽåŸã®ãªã¿ãŒã³ããã©ãŒãã³ã¹ã枬å®ããŸãããªã¹ã¯é¢ã§ã¯ãæå€§ãããŒããŠã³ããã³ãªã¿ãŒã³ãšãããŒããŠã³ã®æ¯çãåæããæ¥µç«¯ãªæå€±ã®ã·ããªãªãç¹å®ããŸããæªåºŠã«ãã£ãŠãªã¿ãŒã³ã®ååžãããã©ãŒãã³ã¹ã«åããããããè©äŸ¡ããŸããå®çŸãã©ãã£ãªãã£ãæšæºåãã¥ã«ãŒã¬ã³ãžãšãã£ããã©ãã£ãªãã£ææšã¯äŸ¡æ Œå€åã瀺ããäžæ¹ãªã¹ã¯èª¿æŽåŸãªã¿ãŒã³ã¯æœåšçãªæå€±ããã³å©çã«é¢ããã€ã³ãµã€ããæäŸããŸããæåŸã«ãå¹³å売買å転çãå転çä¹é¢ãšãã£ãæµåæ§ææšãããã®æ ªåŒã®ååŒãã©ãã ãæŽ»çºãã瀺ããŸãããããã®ææšãçµã¿åãããããšã§ãMiMedx Group Incã®ãªã¹ã¯ããã³ãªã¿ãŒã³ã®ãããã¡ã€ã«ãå€é¢çã«çè§£ã§ãããªã¹ã¯ç®¡çã¹ã³ã¢ã®äžæ žçèŠçŽ ãšãªããŸããã¹ã³ã¢ãé«ãã»ã©ãMiMedx Group Incã®ãªã¹ã¯ã¯äœãããšã瀺ããŸãã